Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Juul Halts Sale of Fruit, Dessert Flavors of E-CigarettesShrinking Youth Group Aids Global Decline in HomicidesWhen Meds Are Free, Patients Take Them More OftenSpurred by Mass Shootings, More Americans View Mentally Ill as ViolentPacemakers, Insulin Pumps Could Be Hacking Targets: FDAAHA News: Make Neighborhoods Green for Heart Health? The Idea Is Taking RootPoll Finds Many Young Americans Think Vaping is SafeWhat Do Hospital Cyber Attackers Want to Know About You?U.S. Minorities' Recent Health Gains May Be SlowingPaid Family Leave Helps Keep Babies' Vaccines on Track: StudyDon't Let Fear of Cancer Keep You From Doctor VisitsMaker Halts Distribution of Generic Zantac Due to Possible CarcinogenCould Profit Be a Factor in Kidney Transplant Decisions?Get Up-to-the-Minute Safety Alerts Sent Straight to Your InboxPurdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 BillionWould a Health Warning on Every Cigarette Help Smokers Quit?Docs Prescribe More Opioids at Certain Time of DayFDA Warns Juul About Illegal Marketing Claims and Pitch to YouthComing Soon: A 'Pot Breathalyzer'?More CT, MRI Scans Being Used, Despite Calls to Cut BackCancer Overtakes Heart Disease as #1 Killer of Middle-Aged in Wealthy NationsOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid ClaimsThousands of Kidneys Thrown Away by U.S. Transplant CentersJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisEvery Sudden Infant Death Deserves a Closer Look: ReportYour Chocolate Pot 'Edible' Could Hold a Hidden DangerCBD Is the Rage, But More Science Needed on Safety, EffectivenessMany Parents Would Switch Doctors Over Vaccination Policy, Poll FindsPot Poisonings Among Kids, Teens Double After Medical Marijuana Law PassedNearly Half of U.S. Patients Keep Vital Secrets From Their DoctorsFDA Proposes Graphic Warning Labels on CigarettesMany Doctors Refusing Care of People Prescribed OpioidsAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesAmericans' Trust in Scientists Follows a Sharp Political DivideRaising Legal Smoking Age to 21 WorksPure CBD Won't Make You Fail a Drug Test, But…Health Tip: Donate Blood SafelyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysResearchers 'Spin' Clinical Trial Findings in Top Psych Journals: StudyMore 'Buyer Beware' Warnings for Unregulated Stem Cell ClinicsSome of Most Common, Deadly Cancers Get the Least Research MoneyTraveling Abroad? Make Sure Your Measles Shot Is Up to DateHey! That's the Wrong Knee, DoctorBlood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke Risk
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Dispensing Opioid Antidote Without a Prescription Might Save Lives

HealthDay News
by -- Robert Preidt
Updated: May 6th 2019

new article illustration

MONDAY, May 6, 2019 (HealthDay News) -- Opioid overdose deaths would decline dramatically if U.S. pharmacists could dispense the antidote naloxone without a doctor's prescription, a new study says.

In states that have adopted such laws, opioid deaths fell an average of 27% in the year after passage and 34% in following years, according to a RAND Corp. analysis of 2005 to 2016 data.

"This is strong evidence that greater use of naloxone can help reduce opioid-related deaths," study co-author David Powell, a senior economist at RAND, said in a news release from the nonprofit research organization.

Before 2010, few states had rules encouraging dispensing of naloxone (Narcan and Evzio) to reverse effects of an opioid overdose. But significant change followed.

By 2014, 15 states gave pharmacists indirect authority to dispense naloxone -- for example, allowing sales to people who meet set criteria such as enrollment in certain treatment programs. By 2016, nine states allowed direct dispensing of naloxone by pharmacists.

Naloxone is typically injected or delivered as a nasal spray.

Laws that stopped short of allowing direct dispensing by pharmacists led to only small reductions in opioid overdose deaths, according to the study published May 6 in the journal JAMA Internal Medicine.

"How laws are structured to increase naloxone use is important. Weaker laws that do not give pharmacists direct dispensing authority did not curb opioid deaths," Powell said.

The researchers also reported that direct dispensing laws were associated with an increase in visits to hospital emergency departments for nonfatal opioid overdoses. However, it was not clear if the increase was caused by fewer patients dying from overdoses or something else, the study authors said.

Lead author Rahi Abouk, an economist at William Paterson University in Wayne, N.J., said the findings highlight the importance of pairing naloxone access laws with effective connections to treatment for patients seen in emergency rooms for overdoses.

"This is the location where such programs may be the most effective," Abouk said.

Since 2014, the annual number of opioid-related deaths in the United States has topped the number caused by car crashes or gun violence. It's also exceeds the number of deaths during the peak of the HIV epidemic in the 1980s.

More information

The U.S. Centers for Disease Control and Prevention has more on opioid overdose.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net